secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001437749-24-023240
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed announces July 23 virtual KOL event on neflamapimod for DLB; no new data disclosed
--------------------------------------------------------------------------------

- Event focused on neflamapimod for dementia with Lewy bodies.
- Presentation available on company website; no material results in 8-K.
- Company may reuse presentation in future investor meetings.
- No forward-looking statements or financial guidance updated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924023240/0001437749-24-023240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924023240/crvo20240722_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-023240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer